Literature DB >> 16000480

Age-related prevalence and distribution of nontuberculous mycobacterial species among patients with cystic fibrosis.

Catherine Pierre-Audigier1, Agnès Ferroni, Isabelle Sermet-Gaudelus, Muriel Le Bourgeois, Catherine Offredo, Hoang Vu-Thien, Brigitte Fauroux, Patricia Mariani, Anne Munck, Edouard Bingen, Didier Guillemot, Gilles Quesne, Véronique Vincent, Patrick Berche, Jean-Louis Gaillard.   

Abstract

We studied the prevalence and species distribution of nontuberculous mycobacteria (NTM) in relation to age in 385 patients with cystic fibrosis (CF) (mean age +/- standard deviation [range], 12.0 +/- 6.1 [1 to 24] years; sex ratio, 0.53) attending three Parisian centers. The overall prevalence of NTM in sputum was 8.1% (31 out of 385). The following NTM were isolated (n = 33): Mycobacterium abscessus (n = 13, 39.4%), Mycobacterium avium complex (MAC) (n = 7, 21.2%), Mycobacterium gordonae (n = 6, 18.2%), and other (n = 7, 21.2%). Sixteen patients met the American Thoracic Society microbiological criteria for NTM infection, including 11 patients positive for M. abscessus, 4 for MAC, and 1 for MAC and Mycobacterium kansasii. The overall prevalence of NTM was significantly lower in patients under 15 years old than for patients equal to or more than 15 years old (4.8 versus 14.9%, respectively; P = 0.001). M. abscessus was isolated at all ages, while MAC was not recovered before 15 years (prevalence of 0.0 and 5.2% in patients aged 1 to 14 and 15 to 24, respectively; P = 0.001).

Entities:  

Mesh:

Year:  2005        PMID: 16000480      PMCID: PMC1169165          DOI: 10.1128/JCM.43.7.3467-3470.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  19 in total

Review 1.  Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1997-08       Impact factor: 21.405

2.  Proficiency testing of clinical microbiology laboratories using modified decontamination procedures for detection of nontuberculous mycobacteria in sputum samples from cystic fibrosis patients. The Nontuberculous Mycobacteria in Cystic Fibrosis Study Group.

Authors:  S Whittier; K Olivier; P Gilligan; M Knowles; P Della-Latta
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

Review 3.  Epidemiology of infection by nontuberculous mycobacteria.

Authors:  J O Falkinham
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

4.  Mycobacterial lung disease in cystic fibrosis: a prospective study.

Authors:  B Fauroux; B Delaisi; A Clément; C Saizou; D Moissenet; C Truffot-Pernot; G Tournier; H Vu Thien
Journal:  Pediatr Infect Dis J       Date:  1997-04       Impact factor: 2.129

5.  Mycobacterium abscessus infection in cystic fibrosis. Colonization or infection?

Authors:  A R Cullen; C L Cannon; E J Mark; A A Colin
Journal:  Am J Respir Crit Care Med       Date:  2000-02       Impact factor: 21.405

6.  Nontuberculous mycobacteria in cystic fibrosis. An autopsy study.

Authors:  J F Tomashefski; R C Stern; C A Demko; C F Doershuk
Journal:  Am J Respir Crit Care Med       Date:  1996-08       Impact factor: 21.405

7.  hsp65 sequencing for identification of rapidly growing mycobacteria.

Authors:  H Ringuet; C Akoua-Koffi; S Honore; A Varnerot; V Vincent; P Berche; J L Gaillard; C Pierre-Audigier
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

8.  Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients.

Authors:  D E Griffith; W M Girard; R J Wallace
Journal:  Am Rev Respir Dis       Date:  1993-05

9.  The role of Mycobacteria Other Than Tuberculosis (MOTT) in patients with cystic fibrosis.

Authors:  K Hjelt; N Højlyng; P Howitz; N Illum; E Munk; N H Valerius; K Fursted; K N Hansen; I Heltberg; C Koch
Journal:  Scand J Infect Dis       Date:  1994

Review 10.  Lung infections associated with cystic fibrosis.

Authors:  Jeffrey B Lyczak; Carolyn L Cannon; Gerald B Pier
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

View more
  56 in total

1.  Molecular fingerprinting of Mycobacterium abscessus strains in a cohort of pediatric cystic fibrosis patients.

Authors:  Kathryn A Harris; Dervla T D Kenna; Cornelis Blauwendraat; John C Hartley; Jane F Turton; Paul Aurora; Garth L J Dixon
Journal:  J Clin Microbiol       Date:  2012-03-07       Impact factor: 5.948

Review 2.  Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

Review 3.  Nontuberculous mycobacteria and the lung: from suspicion to treatment.

Authors:  Emmet E McGrath; Zoe Blades; Josie McCabe; Hannah Jarry; Paul B Anderson
Journal:  Lung       Date:  2010-04-09       Impact factor: 2.584

4.  Multiple strains of non-tuberculous mycobacteria in a patient with cystic fibrosis.

Authors:  Sarah M N Brown
Journal:  J R Soc Med       Date:  2010-07       Impact factor: 5.344

5.  Vaccine strategies against cystic fibrosis pathogens.

Authors:  Vincent Le Moigne; Jean-Louis Gaillard; Jean-Louis Herrmann
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

6.  Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.

Authors:  Valerie Waters; Felix Ratjen
Journal:  Cochrane Database Syst Rev       Date:  2020-06-10

7.  Value of the chlorhexidine decontamination method for recovery of nontuberculous mycobacteria from sputum samples of patients with cystic fibrosis.

Authors:  Agnès Ferroni; Hoang Vu-Thien; Philippe Lanotte; Muriel Le Bourgeois; Isabelle Sermet-Gaudelus; Brigitte Fauroux; Sophie Marchand; Françoise Varaigne; Patrick Berche; Jean-Louis Gaillard; Catherine Offredo
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

8.  Acute respiratory failure involving an R variant of Mycobacterium abscessus.

Authors:  Emilie Catherinot; Anne-Laure Roux; Edouard Macheras; Dominique Hubert; Moussa Matmar; Luc Dannhoffer; Thierry Chinet; Philippe Morand; Claire Poyart; Beate Heym; Martin Rottman; Jean-Louis Gaillard; Jean-Louis Herrmann
Journal:  J Clin Microbiol       Date:  2008-11-19       Impact factor: 5.948

9.  Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis.

Authors:  Stacey L Martiniano; Marci K Sontag; Charles L Daley; Jerry A Nick; Scott D Sagel
Journal:  Ann Am Thorac Soc       Date:  2014-01

Review 10.  Nontuberculous mycobacteria: the changing epidemiology and treatment challenges in cystic fibrosis.

Authors:  Janice M Leung; Kenneth N Olivier
Journal:  Curr Opin Pulm Med       Date:  2013-11       Impact factor: 3.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.